Carcinogenicity of atrazine, alachlor, and vinclozolin

Lancet Oncol. 2025 Nov 21:S1470-2045(25)00702-8. doi: 10.1016/S1470-2045(25)00702-8. Online ahead of print.

Authors

Russell C Cattley¹, Anneclaire J De Roos¹, Daniele Mandrioli¹, Neil Pearce¹, Anjoeka Pronk¹, Anatoly Soshilov¹, Sunny O Abarikwu¹, Isabelle Baldi¹, Dana B Barr¹, Laura E Beane Freeman¹, Sylvie Bortoli¹, Alison Connolly¹, Mohamed A Dalvie¹, Marcelo Jm Ferreira¹, Mary Beth Genter¹, Ludovic Le Hégarat¹, Stefano Lorenzetti¹, John R McLaughlin¹, Peter Møller¹, Cassiana C Montagner¹, Henrique C S Silveira¹, Takeshi Toyoda¹, David H Volle¹, Lamia Benbrahim-Tallaa¹, Aline de Conti¹, Caterina Facchin¹, Andrew T Kunzmann¹, Federica Madia¹, Elisa Pasqual¹, Marie-Laure Aix¹, Xiaobei Deng¹, Rachmad A Dongoran¹, Michael T Olanipekun¹, Eero Suonio¹, Susana Viegas¹, Heidi Mattock¹, Roland Wedekind¹, Mary K Schubauer-Berigan¹

Affiliation

¹ International Agency for Research on Cancer, Lyon, France.

PMID: 41285132
DOI: 10.1016/S1470-2045(25)00702-8

No abstract available